Darifenacin 33342-0276-07

Package NDC

33342-0276-07

Manufacturer: Macleods Pharmaceuticals Limited
Dosage Form: Tablet, Extended Release
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: July 29, 2017
Listing Expires: December 31, 2026
Application: ANDA207302

Need to source Darifenacin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Darifenacin Hydrobromide	7.5 mg/1

Drug Class

Cholinergic Muscarinic Antagonist [EPC]Cholinergic Muscarinic Antagonists [MoA]

Selected Package

33342-0276-07Selected

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-276-07)

Other packages for this product(2)

33342-0276-10

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-276-10)

View →

33342-0276-12

10 BLISTER PACK in 1 CARTON (33342-276-12) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

View →